After 33 years at UB, Luis Colón is retiring, leaving behind a career defined as much by the students he mentored as by the ...
U.S. drugmaker Eli Lilly is in advanced talks to acquire biotech firm Kelonia Therapeutics for more than $2 billion, the Wall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results